发明名称 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES
摘要 The invention is a method and composition for the prevention and treatment of type I and type II diabetes in a subject. The composition comprises an IgG-Fc fusion protein where the fusion protein comprises GLP-1, mutant GLP-1, or exendin-4.
申请公布号 EP1920061(A4) 申请公布日期 2009.05.13
申请号 EP20060761187 申请日期 2006.07.27
申请人 WANG, QINGHUA 发明人 PRUD'HOMME, GERALD, J.;KUMAR, MOHAN
分类号 C12N15/62;A61K38/26;A61K47/48;C07K14/605;C07K16/00;C07K19/00;C12N1/21;C12N5/10;C12N15/13;C12N15/16;C12N15/63;C12P21/02 主分类号 C12N15/62
代理机构 代理人
主权项
地址